Matthew Simms

Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial

Christopher Parker, Noel W. Clarke, Adrian Cook et al. · The Lancet · 2020 · 403 citations · Full text

Medicine, Radiation Oncology, Urology +11

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial

N.W. Clarke, Amin Ali, Fiona C. Ingleby et al. · Annals of Oncology · 2019 · 398 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Matthew R. Sydes, Melissa Spears, Malcolm D. Mason et al. · Annals of Oncology · 2018 · 250 citations · Full text

Medicine, Oncology, Urology +17

JAK-STAT Blockade Inhibits Tumor Initiation and Clonogenic Recovery of Prostate Cancer Stem-like Cells

Paula Kroon, Paul A. Berry, Michael J. Stower et al. · Cancer Research · 2013 · 175 citations

Medicine, Cancer Biology, Oncology +17

Low-temperature plasma treatment induces DNA damage leading to necrotic cell death in primary prostate epithelial cells

Adam M. Hirst, Matthew Simms, V. M. Mann et al. · British Journal of Cancer · 2015 · 173 citations · Full text

Life Sciences, Cell Biology, Urology +17